U.S. flag

An official website of the United States government

NM_000036.3(AMPD1):c.1235C>T (p.Ala412Val) AND Muscle AMP deaminase deficiency

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 25, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002751285.4

Allele description [Variation Report for NM_000036.3(AMPD1):c.1235C>T (p.Ala412Val)]

NM_000036.3(AMPD1):c.1235C>T (p.Ala412Val)

Gene:
AMPD1:adenosine monophosphate deaminase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p13.2
Genomic location:
Preferred name:
NM_000036.3(AMPD1):c.1235C>T (p.Ala412Val)
HGVS:
  • NC_000001.11:g.114677504G>A
  • NG_008012.1:g.23052C>T
  • NM_000036.3:c.1235C>TMANE SELECT
  • NM_001172626.2:c.1223C>T
  • NP_000027.3:p.Ala412Val
  • NP_001166097.2:p.Ala408Val
  • NC_000001.10:g.115220125G>A
Protein change:
A408V
Molecular consequence:
  • NM_000036.3:c.1235C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001172626.2:c.1223C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Muscle AMP deaminase deficiency (MMDD)
Synonyms:
Myoadenylate deaminase deficiency, myopathy due to; Adenosine monophosphate deaminase 1 deficiency; AMP deaminase 1 deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0014220; MedGen: C3714933; Orphanet: 45; OMIM: 615511

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003019936Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Nov 25, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical Utility of Rapid Exome Sequencing Combined With Mitochondrial DNA Sequencing in Critically Ill Pediatric Patients With Suspected Genetic Disorders.

Ouyang X, Zhang Y, Zhang L, Luo J, Zhang T, Hu H, Liu L, Zhong L, Zeng S, Xu P, Bai Z, Wong LJ, Wang J, Wang C, Wang B, Zhang VW.

Front Genet. 2021;12:725259. doi: 10.3389/fgene.2021.725259.

PubMed [citation]
PMID:
34490048
PMCID:
PMC8416976

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003019936.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 445 of the AMPD1 protein (p.Ala445Val). This variant is present in population databases (rs770870863, gnomAD 0.003%). This missense change has been observed in individual(s) with AMPD1-related conditions (PMID: 34490048). ClinVar contains an entry for this variant (Variation ID: 1981141). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024